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Background: Staphylococcus aureus and other coagulase-positive staphylococci (CPS) colonize skin and mucous
membrane sites and can cause skin and soft tissue infections (SSTIs) in humans and animals. Factors modulating
methicillin-resistant S. aureus (MRSA) colonization and infection in humans remain unclear, including the role of the
greater microbial community and environmental factors such as contact with companion animals. In the context of
a parent study evaluating the households of outpatients with community MRSA SSTI, the objectives of this study
were 1) to characterize the microbiota that colonizes typical coagulase-positive Staphylococcus spp. carriage sites in
humans and their companion pets, 2) to analyze associations between Staphylococcus infection and carriage and the
composition and diversity of microbial communities, and 3) to analyze factors that influence sharing of microbiota
between pets and humans.
Results: We enrolled 25 households containing 56 pets and 30 humans. Sampling locations were matched to
anatomical sites cultured by the parent study for MRSA and other CPS. Bacterial microbiota were characterized by
sequencing of 16S ribosomal RNA genes. Household membership was strongly associated with microbial communities,
in both humans and pets. Pets were colonized with a greater relative abundance of Proteobacteria, whereas people
were colonized with greater relative abundances of Firmicutes and Actinobacteria. We did not detect differences in
microbiota associated with MRSA SSTI, or carriage of MRSA, S. aureus or CPS. Humans in households without pets were
more similar to each other than humans in pet-owning households, suggesting that companion animals may play a
role in microbial transfer. We examined changes in microbiota over a 3-month time period and found that pet
staphylococcal carriage sites were more stable than human carriage sites.
Conclusions: We characterized and identified patterns of microbiota sharing and stability between humans and
companion animals. While we did not detect associations with MRSA SSTI, or carriage of MRSA, S. aureus or CPS in this
small sample size, larger studies are warranted to fully explore how microbial communities may be associated with and
contribute to MRSA and/or CPS colonization, infection, and recurrence.
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Methicillin-resistant Staphylococcus aureus (MRSA) is a
major cause of skin and soft tissue infections (SSTI),
with 80,000 invasive MRSA SSTI and 11,000 resultant
deaths reported in the United States in 2011 [1]. Rates
of asymptomatic nasal colonization in the general public
range from 1.5% for MRSA to ≥30% for S. aureus at any
given time [2,3]. Pets, including cats, dogs, horses, and
exotic species, may carry methicillin-susceptible S. aureus
(MSSA) and MRSA but more commonly are colonized by
other coagulase-positive staphylococci (CPS), particularly
S. pseudintermedius and S. schleiferi, which can also carry
genes conferring resistance to β-lactam antimicrobials and
cause SSTI [4-6].
The natural reservoir of S. aureus is the anterior
nares as well as other anatomical skin sites in humans,
particularly the axillae and groin [7]. In animals, the nares,
mouth, and perineum are typical CPS carriage sites [8].
The skin, a common site of staphylococcal infection in
both humans and animals, is the body’s interface with the
external environment and an ecosystem harboring diverse
microbial populations that provide important functions to
the host. Vital functions of the skin’s microbiome include
provision of a blockade to opportunistic and pathogenic
microorganisms, and contributions to the regulation of
immunity and inflammation [9-11]. Thus, the skin micro-
biota may modulate cutaneous infection and disease, such
as SSTI caused by staphylococci.
The role of microbiota in modulating resistance to
pathogenic and opportunistic microorganisms and in
regulating the host immune response is increasingly
evident; furthermore, pathogens function in the context of
microbial communities. For example, the skin commensal
S. epidermidis can inhibit S. aureus colonization and
biofilm formation in the nares [12]. S. epidermidis can also
act as a reservoir of antibiotic-resistance genes and other
genetic elements that are readily transferred to S. aureus
via horizontal gene transfer [13]. These potentially counter-
productive functions illustrate the complexity of microbe-
microbe interactions as they relate to S. aureus colonization
and infection.
The primary mode of MRSA transmission is through
direct contact, for example with a colonized or infected
individual [14,15]. Even with antibiotic treatment and
decolonization protocols, MRSA may continue to be carried
asymptomatically by humans [16,17]. Indeed, recurrent
MRSA infection has been reported in up to 31% of those
affected within 6 months of the first SSTI [18]. Companion
animals and other household factors may play a role in
MRSA SSTI recurrence [19-21]. Recent findings that dog
ownership increases the degree of shared skin microbiota
within households underscores the potential role that pets
may play in sharing of microbiota [22]. Therefore, studying
human and companion animal populations in parallelmay provide greater insight into the dynamics governing
CPS-microbiota-host interactions.
We hypothesized that microbial communities, particularly
at anatomical sites associated with staphylococcal carriage,
may play a role in MRSA (or other CPS) colonization,
carriage, infection, and recurrence. We further hypothesized
that companion animals living in the household may partici-
pate in sharing of microbiota. To test these hypotheses, we
used culture-independent sequencing of the bacterial 16S
ribosomal RNA (rRNA) gene to characterize microbiota
colonizing humans and their companion animals in house-
holds. Sampling of subjects was conducted in the context of
a larger study which enrolled household members and pets
of index patients diagnosed with an MRSA SSTI. Our
objectives were to 1) characterize the microbiota colonizing
anatomical sites of staphylococci carriage in humans and
their companion animals, 2) analyze associations between
MRSA and CPS infection and carriage and the composition
and diversity of the microbial community, and 3)
analyze factors that influence sharing of microbiota




Twenty-five households were enrolled and sampled,
representing 78% of homes enrolled between July and
December 2012 in the parent study. Six households
without pets were excluded due to pending IRB oversight
at the time of the study visit; one household with a single
dog was excluded from animal sampling due to dog
aggression (humans were not eligible to be sampled at that
study visit). Humans were sampled from seven households,
of which four (57%) had pets. Eighteen households were
enrolled from which only pets participated in the study.
Households in which people were sampled were similar in
terms of the number of human household members and
number of companion animals in the household compared
to households in which only pets were sampled.
Three-month follow-up sampling
Twenty households (80%) remained in the study and
participated in the follow-up home study visit 3 months
after the baseline study visit. This study visit followed a
1-week treatment of people with nasal mupirocin oint-
ment and chlorhexidine body washes in the 12 homes
randomized to receive it. Pets were not treated.
Only cats and dogs were included in our analyses
of pets. Samples from other mammalian pets were
collected but not included in the analyses due to
small sample size (four hamsters, one ferret, one
rabbit, and one sugar glider). All of these “pocket pet”
species were resident in homes in which dogs and/or
cats also were present.
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sites of staphylococcal carriage
Characteristics of households and study participants
(human and companion animal) according to visit are
provided in Table 1, which demonstrates that human sub-
jects were of working age or younger (≤65 years old), and
companion animals ranged in age from two to 135 months
(≤12 years old). From 288 samples (34 cat nares, 34 cat
mouths, 53 dog nares, 55 dog mouths, 51 human nares,
51 human axillae/groin, and 10 human lesion site sam-
ples), 11,474,465 sequences were obtained and analyzed.
Sequence counts stratified by host species and anatomical
site are shown in Additional file 1: Table S1. The taxo-
nomic relative abundance data for the “pocket pets” are
illustrated in Additional file 2: Figure S1.
To obtain an overall view of pet microbiota and how
they compare to humans at anatomical sites of staphylo-
coccal carriage sampled in the parent study, we calculated
the weighted UniFrac metric to infer distances between
communities and visualized all samples using principal
coordinates analysis (PCoA) (Figure 1A). Host species
and anatomical site had a strong, significant effect on
microbial community composition (R = 0.58; weighted
UniFrac; p < 0.001; Table 2). The bacterial genus-level
taxa contributing to the clustering, and representing
57.1% of the sequences, are represented by grey circles in
Figure 1A. Because not all sampled anatomical sites were
consistent across all host species, we specifically compared
nasal microbiota to examine differences between cats,
dogs, and humans, as all host species were sampled
from the nares. Again, host species had a significant
effect on the nares microbiota (R = 0.43; weighted
UniFrac; p < 0.001; Table 2). Bacillales and Actinomycetes
cluster with human nasal microbiota and include the
genera Corynebacterium and Staphylococcus, consistent
with previous studies of the nasal microbiota of healthy
humans [23,24]. Cat and dog nasal microbiota clustered
with Gram-negative Proteobacteria such as Moraxella and
unclassified Pasteurellaceae.
These taxonomic differences in cat and dog microbiota,
compared to human microbiota, are underscored when
examining relative abundance even at the phylum level. In
cats and dogs, Proteobacteria is the dominant bacterial
phylum, followed by Bacteroidetes and Firmicutes
(Figure 2A–D). Less abundant phyla include Fusobac-
teria, Spirochaetes, Tenericutes, and SR1 (Additional file 3:
Table S2). In humans, Firmicutes is the dominant phylum,
followed by Actinobacteria in the skin inguinal crease
and axillae sites, or Proteobacteria in the nares. At the
genus level, unclassified Moraxellaceae and unclassified
Pasteurellaceae, both of phylum Proteobacteria, were
the two most abundant genera present in cats and dogs
(Figure 2A–D). Corynebacterium and Staphylococcus, of
phylum Actinobacteria and Firmicutes, respectively, werethe most abundant genera in humans (Figure 2E–F). A
complete genus-level relative abundance table of all
samples is found in Additional file 3: Table S2. The short
read lengths employed in this study precluded us from
resolving species-level taxonomic assignments.
To quantify and compare alpha diversity, we calculated
and compared the Shannon diversity index for all host
species and sites. These index values were overlaid on a
weighted UniFrac PCoA plot, illustrating the host species
and site specificity of clustering (Figure 1B–C). The cat
oral cavity contained the greatest alpha diversity (a median
Shannon index value of 7.0), while the dog oral cavity had
significantly lower alpha diversity in comparison (median
Shannon index value of 5.6; p = 2.6 × 10−8; Figure 1C). In
dogs, the oral cavity had significantly higher Shannon
diversity index values than the nares (median Shannon
index value of 3.2; p = 1.8 × 10−7).
To identify potential signature microbiota of host species
and anatomical sites, we identified operational taxonomic
units (OTUs) present in 90% and 100% of sample types and
their respective relative abundances (Additional file 4:
Table S3). Ninety percent of cat nares contained OTUs
classified as Staphylococcus, which belonged to the same
OTU that was present in 100% of human nares, inguinal/
axilla, and lesion samples. Core OTUs of the cat nares only
comprised 13.1% total relative abundance, whereas core
OTUs of the cat oral cavity comprised 19.0% of total
relative abundance and included many OTUs classi-
fied as anaerobes (Porphyromonadaceae, Clostridiales, and
Bacteroides), Streptococcus, and various Gram-negative bac-
teria (Pasteurella, Moraxella, and Kingella). The dog oral
cavity contained similar core OTUs as the cat oral cavity
and comprised 29.1% of total bacterial relative abundance.
Core OTUs of dog nares comprised 50.5% of total relative
abundance and consisted of Moraxellaceae, Staphylococcus,
and unclassified Gammaproteobacteria OTUs. Core OTUs
of the human inguinal/axilla comprised 34.5% of
bacterial relative abundance and included OTUs clas-
sified as Staphylococcus, Corynebacterium, and Finegoldia,
whereas core OTUs of the nares comprised 18.1% of relative
abundance and additionally included OTUs classified as
Streptococcus and Enhydrobacter. Taken together, these
observations indicate that composition and diversity of
microbial communities are variable across anatomical sites of
sampling and host species. We therefore analyzed anatomical
sites individually (as opposed to collectively) when examining
the microbiota with respect to MRSA and CPS infection
and/or carriage and sharing in households.
Microbial community composition in index subjects with
MRSA SSTI
We examined the microbiota colonizing healing lesions
caused by MRSA SSTI in the index subjects (n = 6) en-
rolled in the study. In addition to Staphylococcus, which
Table 1 Study demographics
Total sampled Humans only Humans and pets Pets only
Baseline study visit
Households
Number of households 25 3 4 18
Number of people, median (range) 4 (1–8) 4 (2–5) 5 (4–7) 4 (1–8)
Number of pets, median (range) 2 (0–13) 0 2 (1–10) 2 (1–13)
Human subjects
Index subjects 6 3 3 -
Female:male 3:3 2:1 1:2 -
Age in years, median (range) 8.5 (2–48) 5 (2–48) 13 (6–15) -
CPS + at any site, n = 4 3 1 2
S. aureus + at any site, n = 4 1 1 0
MRSA + at any site 1 1 0 -
Non-index subjects 24 7 17 -
Female:male 12:12 4:3 8:9 -
Age in years, median (range) 25 (3–54) 23 (9–42) 26 (3–54) -
CPS + at any site, n = 18 15 1 14
S. aureus + at any site, n = 18 3 0 3
MRSA + at any site 3 0 3 -
Pet subjects
Dogs 36 - 5 31
Female:male 21:15 - 3:2 18:13
Age in months, median (range) 24 (2–132) - 24 (6–120) 24 (2–132)
Neutered:unneutered 9:27 - 1:4 8:23
CPS + at any site 34 - 4 30
S. aureus + at any site 6 - 1 5
MRSA + at any site 2 - 2 0
Cats 20 - 3 17
Female:male 11:9 - 3:0 8:9
Age in months, median (range) 27 (4–135) - 12 (8–20) 53 (4–135)
Neutered:unneutered 16:4 - 2:1 14:3
CPS + at any site 13 - 2 11
S. aureus + at any site 4 - 1 3
MRSA + at any site 2 - 2 0
Three-month follow-up study visit
Households
Number of households 20 2 3 15
Number randomized to treatment 12 2 2 8
Number of people, median (range) 4 (1–8) 4.5 (4–5) 5 (4–7) 4 (1–8)
Number of pets, median (range) 2 (0–10) 0 2 (1–8) 3 (1–10)
Human subjects
Index subjects 4 2 2 -
Randomized to treatment 3 2 1 -
Female:male 1:3 1:1 0:2 -
Age in years, median (range) 9 (2–15) 3.5 (2–5) 14 (13–15) -
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Table 1 Study demographics (Continued)
CPS + at any site, n = 4 3 0 3
S. aureus + at any site, n = 4 1 0 1
MRSA + at any site 0 0 0 -
Non-index subjects 17 6 11 -
Randomized to treatment 14 6 8
Female:male 8:9 3:3 5:6 -
Age in years, median (range) 26 (3–54) 21 (9–42) 26 (3–54) -
CPS + at any site, n = 14 11 3 8
S. aureus + at any site, n = 14 4 1 3
MRSA + at any site 0 0 0 -
Pet subjects
Dogs 19 - 4 15
Female:male 12:7 - 2:2 10:5
Age in months, median (range) 37 (6–132) - 42 (6–120) 37 (9–132)
Neutered:unneutered 7:12 - 1:3 6:9
CPS + at any site 17 - 3 14
S. aureus + at any site 4 0 4
MRSA + at any site 3 - 0 3
Cats 14 - 2 12
Female:male 8:6 - 2:0 6:6
Age in months, median (range) 15 (4–135) - 10 (8–12) 23 (4–135)
Neutered:unneutered 10:4 - 1:1 9:3
CPS + at any site 11 - 1 10
S. aureus + at any site 4 0 4
MRSA + at any site 1 - 0 1
For pet-only households, humans were present, but were not eligible for participation. Data from the 3-month follow-up visit are limited to people and pets
sampled longitudinally, excluding new household members present at the 3-month visit.
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(range: 0.25%–46.75%), the genus-level taxa found at
the highest relative abundances in the lesions were
(in descending order) Corynebacterium, Acinetobacter,
unclassified bacteria, Streptococcus, Pseudomonas, Prevo-
tella, Micrococcus, unclassified Enterobacteriaceae, and
unclassified Pasteurellaceae (Figure 2G). All healing MRSA
lesions contained OTUs classified as Staphylococcus, Cor-
ynebacterium, Micrococcus, and Streptococcus (Additional
file 4: Table S3).
We compared the microbiota of index and non-index
human subjects of the nares and the inguinal crease/
axilla regions to determine if recent MRSA SSTI was
associated with differences in microbial community
composition at these carriage sites. Overall, no differences
were detected using alpha- or beta-diversity metrics
(Table 3), and no taxa were differentially represented.
Together, these results indicate that recent MRSA
SSTI may not be associated with differences in microbial
community composition and diversity at staphylococcal
carriage sites, or our sample size was not sufficient todetect significant differences. Alternatively, our findings
could be a result of the initial treatment regimens pre-
scribed by diagnosing physicians for the index subjects,
given that only one of six index subjects was positive for
MRSA carriage at the initial sampling visit.
Microbial communities associated with MRSA, S. aureus,
and CPS carriage
To determine if MRSA, S. aureus, and CPS carriage are
associated with differential composition and diversity of
the greater microbial community, we used culture-based
techniques to determine which human study participants
were colonized with CPS, S. aureus, and MRSA by nasal
and skin swabs and which pets were colonized with
CPS, S. aureus, and MRSA by nasal and oral swabs. Only
4/30 human subjects were positive for MRSA carriage
by these techniques, 1 of which was an index subject
presenting with SSTI. Microbial community structure
and membership were not significantly different in the
axilla/inguinal or nasal sites when comparing MRSA car-















































Figure 1 Distinct microbiomes colonize staphylococcal carriage sites of dogs, cats, and humans. (A) Weighted UniFrac metric principal
coordinates analysis (PCoA) comparing the microbiomes of cat oral cavities (red circles), cat nares (red squares), dog oral cavities (green circles),
dog nares (green squares), human inguinal creases/axillae (blue triangles), human nares (blue squares), and human healing lesions (blue stars).
The grey circles represent the six most abundant genus-level consensus taxonomies (unclassified Moraxellaceae, Corynebacterium, Staphylococcus,
unclassified Pasteurellaceae, Moraxella, and Streptococcus) contributing to variation, and size of spheres indicates relative abundance. Percent variation
explained by PC1 and PC2 is represented in parentheses by each axis. (B) Alpha diversity characteristics of pet and human Staphylococcus carriage sites,
visualized by the weighted UniFrac metric PCoA comparing microbial communities and alpha diversity (Shannon diversity index) overlaid on the same
PCoA plot. (C) Shannon diversity index values comparing cat, dog, and human staphylococcal carriage sites are depicted with each circle representing
one sample and medians indicated by red lines.
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to non-carriers (n = 18) or CPS carriers (n = 18) to
non-carriers (n = 4) among humans, although these
comparisons were limited to the 22 participants for
whom swabs were available for a second microbial
culture using methods harmonized with the animal
protocol. In cats, CPS, S. aureus, and MRSA carriage
in the oral cavity and nares were not associated with
significant changes in microbial community composition or
diversity. CPS carriage status in dogs was associated with
oral cavity microbiota changes, as measured only by the
unweighted UniFrac metric (R = 0.2495, p < 0.05). CPS
carriage did not result in dog nasal microbiota differencesas determined by the metrics (Table 3). As the majority of
CPS cultured from our population of dogs were identified
by Polymerase chain reaction (PCR) as S. pseudintermedius,
with a prevalence rate of 42% among dogs sampled at base-
line, we also performed evaluations for S. pseudintermedius
nasal and oral carriage. However, we did not find any
significant associations with microbial community compos-
ition or diversity (data not shown). In dogs, S. aureus and
MRSA carriage in the oral cavity and nares also were not
associated with significant changes in microbial community
composition or diversity (Table 3).
To further examine microbial interactions in the con-
text of MRSA nasal carriage in humans, we inferred
Table 2 Association of different factors with microbial communities at staphylococcal carriage sites at the baseline visit
Comparison category Host species Anatomic site Beta diversity metric R statistic and significance
Host species and anatomical site (cat, dog,
or human and nares, oral cavity or inguinal/axilla)
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Table 2 Association of different factors with microbial communities at staphylococcal carriage sites at the baseline visit
(Continued)




Summarized are ANOSIM analyses assessing association of various metadata on microbial community distances measured using weighted and unweighted
UniFrac, Bray-Curtis index, and Jaccard index. *p < 0.05, **p < 0.005, and ***p ≤ 0.001 (FDR adjusted values).
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for nasal MRSA carriage (Additional file 5: Figure S2)
and individuals negative for nasal MRSA carriage
(Additional file 5: Figure S2). Networks were constructed
using only OTUs found at greater than 0.1% relative
abundance in their respective groups, and only signifi-
cant interactions (Fisher’s Z; q = 0.05) are shown. In
MRSA-positive individuals, Staphylococcus and Wautersiella
OTUs were negatively correlated (q= 0.034; Additional file 5:
Figure S2). In MRSA-negative individuals, no OTUs
were significantly positively or negatively correlated
with Staphylococcus OTUs (Additional file 5: Figure S2).
However, an unclassified Staphylococcaceae OTU was
positively correlated with a number of OTUs including
Lactobacillus, Acinetobacter, Jeotgalicoccus, Psychrobacter,
and Sphingobacterium. These findings suggest that OTU
interactions may be different depending on MRSA
carriage status, but need to be confirmed in larger cohorts.
Factors that may facilitate sharing of microbiota between
humans and pets
The contact that pets and their owners share can be a
factor in the mutual transmission of microbiota. Because
previous findings by Song et al. [22] demonstrated that dog
ownership increased sharing of microbiota in households,
particularly skin microbiota, we analyzed the effect of
cohabitation and pet ownership on household microbial
community composition at sites of Staphylococcus carriage.
Pet ownership did not have a significant effect on microbial
communities of the nares or the inguinal/axilla microbiota
in humans (Table 2). Cohabitating human and pet subjects
shared more of their microbiota with their household
members than with humans and pets living outside of the
household (Table 2). In particular, household had a strong
effect on the human nares microbiota, with higher R values
for beta-diversity metrics that were not weighted for abun-
dance (R = 0.49 unweighted UniFrac and R = 0.50 binary
Jaccard index; both p < 0.005), suggesting that rarer OTUs
are contributing to differences within the microbial com-
munities observed among households. Unweighted beta-
diversity metrics were also significant for inguinal/axilla
microbiota, but with lower R values (R = 0.19 for binary
Jaccard index, p < 0.01). Household membership similarlywas associated with cat and dog microbiota (Table 2),
though the greatest effect observed was for cat nares, again
using unweighted beta-diversity metrics (R = 0.95 for the
binary Jaccard index; p < 0.005; R = 0.75 for the unweighted
UniFrac index, p < 0.005). When comparing the microbiota
of members within the household, people who did not
have pets in their households were more similar to each
other than people that did have pets in their households, in
both the inguinal/axilla regions (p < 0.001); Figure 3A) and
the nares (p < 0.05; Figure 3B).The stability of microbiota colonizing staphylococcal
carriage sites
To understand how microbiota of staphylococcal carriage
sites change over a period of 3 months in cat, dog, and
human subjects, we examined differences in the microbiota
of subjects present at both study visits. The paired
relative abundance graphs are illustrated for individual
cat (Additional file 6: Figure S3), dog (Additional file 7:
Figure S4), and human (Additional file 8: Figure S5)
microbiota at baseline and 3 months, respectively.
The core microbiomes of each host species and anatom-
ical site were determined by identifying OTUs present in at
least 90% of host species and anatomical sites at both study
visits (Additional file 9: Table S4). To further determine
which OTUs were part of the temporally stable micro-
biomes, we performed Wilcoxon rank-sum tests to deter-
mine if those OTUs fluctuated significantly over time.
Approximately 12%–15% of the cat oral microbiome was
temporally stable, containing OTUs belonging to the fam-
ilies Porphyromonadaceae, Pseudomonadales, and Pasteur-
ellaceae, and class Clostridiales. Approximately 13%–19%
of the cat nasal microbiome was temporally stable, contain-
ing OTUs belonging to the Pasteurellaceae and Moraxella-
ceae, and Staphylococcus (Additional file 9: Table S4).
Approximately 33%–51% of the core dog nasal
microbiome was temporally stable and also contained
Staphylococcus OTUs. The OTUs that did significantly
differ temporally were Conchiformibius and unclassified
Pasteurellaceae, both increasing in relative abundance over
the 3-month time period (p= 0.012 and p= 0.021, respect-
ively). Dog oral cavity temporal core microbiome OTUs
A) Cat Oral Cavity (n=20) B) Cat Nares (n=20)
C) Dog Oral Cavity (n=36) D) Dog Nares (n=36)




















































































Figure 2 Taxonomic classification of microbiota colonizing pet and human sites of Staphylococcus carriage and lesions. Bacterial
relative abundance of (A) cat oral cavity, (B) cat nares, (C) dog oral cavity, (D) dog nares, (E) human combined inguinal crease/axillae, (F) human
nares, and (G) human healing lesions. The genera are colored by their phylum membership: Proteobacteria: green (Gammaproteobacteria) and
yellow (Betaproteobacteria); Firmicutes: red/pink (Bacilli) and orange (Clostridia); Actinobacteria: blue; Bacteroidetes: purple; Fusobacteria: brown;
Tenericutes: black; all others: grey).
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Table 3 Association of staphylococcal carriage with microbial communities at carriage sites at the baseline visit
Comparison category Host species Anatomic site Beta diversity metric R statistic and significance
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Table 3 Association of staphylococcal carriage with microbial communities at carriage sites at the baseline visit
(Continued)




























Summarized are ANOSIM analyses assessing association of various metadata on microbial community distances measured using weighted and unweighted
UniFrac, Bray-Curtis index, and Jaccard index. *p < 0.05 (FDR adjusted value).
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and Pasteurellaceae and comprised 24% of the microbiota at
that site (Additional file 9: Table S4).
Temporally stable OTUs in human healing lesions
included Corynebacterium, Micrococcus, Staphylococcus,
Streptococcus, Anaerococcus, and Finegoldia but only
made up 9%–10% of the colonizing microbiota. In the
human nares, Staphylococcus and Streptococcus OTUs
were stable over time and generally comprised 10%–18%
of the colonizing microbiota. Corynebacterium and
Staphylococcus OTUs were temporally stable in the inguinal
crease/axilla microbiome. However, one Corynebacterium
OTU in the inguinal crease/axillae samples significantly
increased in relative abundance during this time period
(p = 0.028), but overall, 34%–36% of the colonizing micro-
biota was temporally stable (Additional file 9: Table S4).Differences in microbiota over the two time points were
also assessed using beta-diversity metrics (Table 4). The cat
and dog oral and nasal microbiota did not significantly
change by these metrics. Only the human nares and
inguinal/axillae temporally changed significantly in
microbiota composition by beta-diversity metrics over the
3 months (unweighted UniFrac and binary Jaccard,
p = 0.02 for all). In the inguinal crease/axillae samples, a
Corynebacterium OTU varied over time (p = 0.03)
(Additional file 9: Table S4). Community differences were
detected using unweighted beta diversity metrics, indicat-
ing that rarer taxa are likely contributing to these shifts.
These temporal microbial community shifts, as measured
by the unweighted Unifrac and median intersample
dissimilarity score, are illustrated in Figure 4. Human





































   
   
   
   
   
   
   
   
   
   
   
   
   





























   
   
   
   
   
   
   
   
   
   
   
   
   
   







Figure 3 Effect of pet ownership on sharing of microbiota at
human Staphylococcus carriage sites. Depicted are unweighted
UniFrac distances between members of households with pets,
members of households without pets, and members of different
households (inter-household). The boxes represent the interquartile
range (IQR). The whiskers represent the range, excluding outliers. The
line in the middle of boxes represents the median. (A) Inguinal/axilla
distances. (B) Nares distances. *p < 0.05, ***p < 0.001 (FDR corrected).
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change at nares or inguinal crease/axillae sites, when
compared to non-pet owners.
Four of six households with human participants were
randomized to treatment, although index participants
were sampled at both visits in only three of these
households and only two of these households reported
compliance with medication usage according to the
study decolonization protocol. Mupirocin (nares) and
chlorhexidine (skin) decolonization strategy was not
correlated with shifts in microbial communities betweenbaseline and 3-month visits, regardless of analysis accord-
ing to intention-to-treat or analysis as-treated based on
participant report of compliance.
To explore the diversity of species within the genus
Staphylococcus over time, we identified a subset (nares
and lesion site only) of archived staphylococcal isolates
from people (Additional file 10: Table S5). Overall, S. epi-
dermidis was the most commonly identified non-aureus
staphylococcal isolate, with nasal carriage found in 12 par-
ticipants (1 index, 11 household members) at the baseline
visit, nasal carriage found in 9 participants (2 indexes, 7
household members) at the 3-month visit, and lesion-
site contamination found in 3 index participants at
the 3-month visit. Other staphylococcal species found
at the nares site were (in decreasing order of
frequency): S. haemolyticus (n = 4), S. cohnii (n = 2),
S. lugdunensis (n = 2), and with n = 1 each, S. capitis,
S. intermedius, S. kloosii, and S. warneri. None of the
participants with S. epidermidis nasal colonization were
nasally colonized with S. aureus at the baseline visit. Ac-
counting for correlation of data within person and within
household over time, S. epidermidis nasal carriage was
associated with protection against S. aureus nasal carriage
(OR 0.19 [95% confidence interval: 0.02, 1.79]), but this
estimate of association was not statistically significant
(p = 0.14). Model results were similar with inclusion of
index participant status and decolonization treatment
prior to the 3-month visit.
Discussion
Here, we report the microbiota colonizing humans and
companion animals at sites of typical Staphylococcus
carriage. Pet oral cavity and nasal microbiota were
predominantly colonized with Proteobacteria, whereas
humans were colonized with greater relative abundances
of Firmicutes and Actinobacteria. Upon examination of
microbiota colonizing staphylococcal SSTI lesions, we
observed a great diversity of microbiota in the lesion and
unexpectedly low relative abundance of Staphylococcus sp.
We did not detect association of microbial communities
with MRSA SSTI, MRSA carriage, S. aureus carriage,
CPS carriage, or human decolonization treatment. We
additionally found that humans and pets living in the
same household share more microbiota with each
other than with human and pets in different households,
and pet ownership is associated with diversity of human
microbiota within the same household. Finally, we assessed
the stability of the microbiota at staphylococcal colonization
sites over a 3-month time span and noted that only human
microbiota was significantly shifted over time.
Our findings of human microbiota composition are
consistent with previously published studies of microbiota
colonizing human nares and the inguinal crease/axillae
[23-25]. Culture-based analysis of cat and dog oral cavity
























































ANOSIM analyses summary assessing various metadata associations of
microbial community distances over two time points using weighted and
unweighted UniFrac, Bray-Curtis, and Jaccard indexes. *p < 0.05 and **p <
0.005 (FDR adjusted).
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with streptococci were among the most prevalent bacteria
in pets not exposed to MRSA-carrying humans [26]. The
dog oral cavity microbiota, as characterized by 16S rRNA
sequencing, revealed many previously unnamed bacterial
taxa [27,28]. In our study, these unknown taxa are reflected
in the genus-level classifications, with six of the top ten
genera being “unclassified”. In a separate study of culture-independent analysis of six healthy canine oral cavities,
Bacteroidetes was found to be the most abundant phylum
[28], while our analyses found that Proteobacteria was
the most abundant phylum. Unlike our study and that
of Sturgeon et al. [28], Dewhirst et al. did not find
Staphylococcus sp. to be in the canine oral cavity micro-
biota, but Firmicutes and Proteobacteria were the most
abundant phyla recovered in that study of 51 dogs [27].
Similar to our study, a previous report of the feline oral
microbiome found that Proteobacteria was the predomin-
ant phylum [29]. Compared to other sites sampled in this
study, cat oral cavity was the most diverse and significantly
more diverse than the dog oral cavity.
People in households who own pets were colonized
with less similar (more diverse) microbiota compared to
each other than to people in households without pets.
This may indicate enhanced microbial sharing and per-
haps more diverse microbial inputs related to pet expos-
ure. Evaluation of the same people in households over
time suggests that the magnitude of temporal shifts in
microbial communities within host is not strongly
influenced by pet ownership. Our results are consistent
with a recent study demonstrating that owning a dog in-
creased sharing of microbiota in households, particularly
of the skin, and that human skin was colonized with
microbiota more similar to the dog living in the house-
hold than to other dogs [22]. As Song et al. noted, it is
difficult to ascertain which shared human and pet taxa
are transient and which have a specific niche. Given
recent findings that exposure to pets early in life may be
protective of allergic and atopic disease [30,31], it is im-
portant to understand the role of pets in transfer and
sharing of microbiota, which can influence the immune
response [10].
While we have not determined if all pet species are
transiently or persistently colonized with Staphylococcus
bacteria, our data suggest that the colonization is pro-
tracted in cats, as at least 90% of the cats at both study
visits were nasally colonized with Staphylococcus. How-
ever, it is important to note that cats may not truly
become colonized, as defined by replication of bacteria
at the anatomical site, but instead may have frequent
nasal exposure to human sources of Staphylococcus bac-
teria through interactive behavior. In our sampling
population, owners reported that all cats had at least
some contact with people in the house on a daily basis,
and the Staphylococcus OTUs present in cat nares also
belonged to the core microbiota of the human nares, in-
guinal crease/axilla, and lesion samples. Notably, a limi-
tation of 16S rRNA profiling is that it cannot distinguish
between viable and dead bacteria, as the technique relies
upon DNA amplification. Therefore, these findings may
not represent true colonization but reflect interactive
behavior between pets and humans.
A) Cat Oral Cavity (n=28) B) Cat Nares (n=28)
C) Dog Oral Cavity (n=38) D) Dog Nares (n=34)




































Figure 4 Unweighted UniFrac 3D PCoA illustrating changes in microbiota over 3 months. The panels represent microbial community
changes over time in the (A) cat oral cavity, (B) cat nares, (C) dog oral cavity, (D) dog nares, (E) human inguinal crease/axillae, (F) human nares,
and (G) human healing lesions. Each vector represents the microbial community of an individual at baseline and at 3 months, represented by the
spheres. The sample number, n, is the total sample number from both visits. MID median intersample distances. The R values are obtained from
Table 4; *p < 0.05.
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of households in which humans were enrolled (n = 7)
and a small proportion of MRSA-positive human sub-
jects (4 of 30 enrolled). Larger sampling populations
with comparison groups will be required to conclude
whether MRSA colonization influences microbial com-
munity composition and diversity. Examining staphylo-
coccal carriage in companion animals, we did not detect
any differences in the oral cavity or nasal microbiota that
would suggest that CPS, S. aureus, or MRSA carriage
have an effect on the microbial diversity or composition.
Our study was a small case series, which limits the
generalizability of our findings. Another limitation is that
the V4 region used for sequencing was too short to pro-
vide reliable speciation, particularly for Staphylococcus
bacteria, where several species may have identical or
nearly identical sequences in the V4 region. To explorespeciation further, we identified staphylococcal species
cultured from human nares and lesion site and found that
S. epidermidis and S. aureus were the most common
species. Finally, human subjects in our study were ran-
domized to treatment groups, but participant compliance
with treatment protocols in this sampled group was poor,
which may explain the lack of influence of treatment
on shifts in microbial communities at either nares or
skin over time.
Conclusions
We have determined the microbiota in staphylococcal
carriage sites of index MRSA patients, their household
members, and their mammalian pets over time. Further
extension of this work with larger sample sizes will
provide insight into a potential modifiable target that
may influence MRSA and CPS colonization and infection.
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humans and their companion animals, which could have
potential implications for recurrent MRSA SSTI, atopic
and allergic disease, and other disorders and conditions
where environmental microbial transfer may play a role.Methods
Human and animal subject protections
Prior to study initiation, this protocol was reviewed and
approved as part of a nested study by the University of
Pennsylvania’s Institutional Review Board (protocol 814406)
and the Johns Hopkins University Institutional Animal Care
and Use Committee (protocol SP10H319).Household enrollment
Households were recruited in the context of a study
nested within a randomized controlled trial (RCT) enrolling
participants with laboratory-confirmed MRSA SSTI and
their household members. Eligible index patients presented
to an outpatient practice or emergency department of
one of five adult and/or pediatric hospitals: hospital 1
is a 782-bed urban adult acute care hospital, hospital
2 is a 500-bed urban adult acute care hospital, hospital 3
is a 300-bed urban adult community hospital, hospital 4 is
a 469-bed urban children’s hospital, and hospital 5 is a
551-bed rural adult and pediatric hospital. Prior to
enrollment in the study, all index participants under-
went individual treatment for their MRSA SSTI under
the supervision of the diagnosing physician. All house-
holds enrolled in the nested study between July and
December of 2012 were eligible to participate in compan-
ion animal sampling. All households from enrollment
hospitals 1 to 4 between September and December of
2012 were eligible to participate in human sampling.
Two home visits took place at which sampling was
conducted for microbiota analysis and culture. At each
visit, heads of household were surveyed for household- and
pet-related characteristics via interview using an
iFormBuilder (iFormBuilder, Herndon, VA) application
for iPad (Apple, Cupertino, CA). At the end of the
baseline visit, the parent study randomized people
(both index participants and household members) at
the household level to receive either education (control)
or treatment with twice-daily nasal mupirocin ointment
for a week, with a body wash at the beginning and end of
the week using a 4% chlorhexidine body wash (Hibiclens®,
Mölnlycke Health Care, Norcross, Georgia). Treatment
was scheduled to occur a few weeks after the baseline
visit, and participants completed a diary to indicate their
compliance with the protocol. The second home visit took
place 3 months after the baseline visit, following treatment
of people in households randomized to receive medication.
We limited analysis over time to human and companionanimal subjects present at both visits, excluding any
household members only sampled at the 3-month visit.
Sample acquisition
The choice of anatomical site for microbiota evaluation
was harmonized with sites sampled by the parent study
and the RCT in order to compare culture-dependent
and culture-independent results. Veterinarians wore
freshly laundered scrub jackets and sterile gloves during
all sample collection from animals; humans self-sampled.
The swabs were stored in 0.3 mL Yeast Cell Lysis Solution
(Epicentre Biotechnologies, Madison, WI) at −80°C until
DNA extraction.
Human sampling
Human subjects were asked to self-sample with Eswabs™
(Copan Diagnostics, Murrieta, CA) for microbiologic cul-
ture and Catch-All Sample Collection Swabs (Epicentre
Biotechnologies, Madison, WI) for microbial community
analysis in nares, pooled axillae/groin, and (for index
subjects) at the lesion site. A parent performed the
swab sample collection for young children. Self-swabbing
has been shown to be an effective and sensitive method
for detecting MRSA [32].
Animal sampling
Animal subjects were sampled using Sterile BBL™ cultur-
ettes (BD, Franklin Lakes, NJ) for microbiologic culture,
and Catch-All Sample Collection Swabs (Epicentre Biotech-
nologies, Madison, WI) for microbial community analysis
were used to collect superficial samples from nares and oral
cavity, selected for their propensity as Staphylococcus car-
riage sites during a pilot phase of the parent study.
Culture methods
Eswabs from people were streaked onto BBL CHROMagar
MRSA plates (BD Diagnostic Systems, Sparks, MD) to
identify MRSA colonization. Phenotypic isolates on the
chromogenic media were identified as MRSA, confirmed
by the presence of mecA.
Culturettes from animals were enriched first in Mueller-
Hinton broth + 6.5% NaCl selective for all staphylococci
and incubated 16–20 h at 35°C [33]. MRSA only: From
the overnight incubation, 1 mL of broth was trans-
ferred to 9 mLTryptic Soy Broth + 2.5% NaCl + 3.5 mg/L
cefoxitin + 10 mg/L aztreonam to enrich growth of
beta-lactam-resistant isolates. From each of these broth
enrichment steps, isolates were identified using Columbia
CNA agar (Staphylococcus selective), then transferred
to Baird-Parker agar (selective for coagulase-positive
staphylococci (CPS) and designed for S. aureus). Phe-
notypic isolates on Baird-Parker were identified as pre-
sumptive CPS. All CPS isolates were tested using a
multiplex PCR assay that amplifies species-specific
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addition to veterinary pathogens S. pseudintermedius and
S. schleiferi, as previously described [34]. Methicillin-
resistant isolates (MRSA) were identified by presence of a
mecA/mecC sequence, with ATCC43300 and LGA251 as
mecA- and mecC-positive controls, respectively [35].
Additionally, Eswabs from people were obtained from
the parent study and, following CHROMagar culture,
subjected to the same enrichment and identification
protocol used for elucidation of animal isolates. Coagulase-
negative staphylococcal isolates from the MRSA arm of the
enrichment protocol and CPS isolates from both arms of
the enrichment protocol (MS- and MR-) were archived and
available for additional testing. A subset (nares and lesion
site isolates only) of coagulase-negative staphylococcal
isolates and CPS isolates not identified through the
nuc PCR protocol were submitted for species identification
and antimicrobial susceptibility testing using the BD
Phoenix system (BD Diagnostics, Sparks, MD).
DNA isolation, amplification, and sequencing of 16S
rRNA genes
The Catch-All swab samples were thawed, and 0.5 μL of
Ready-Lyse Lysozyme (Epicentre Biotechnologies, Madison,
WI) was added to each tube and incubated for 1 h
with shaking at 600 rpm and 37°C. The swab was re-
moved, placed into a spin basket, and centrifuged for
1 min at 9,400 × g to extract any remaining liquid. The
sample was then added to a glass bead tube (0.5 mm; MO
BIO, Carlsbad, CA) and vortexed for 10 min at maximum
setting. The samples were then incubated in a heat block
for 30 min at 65°C and 600 rpm, followed by ice for 5 min
and a brief spin. A 150 μL of Protein Precipitation Buffer
(Epicentre Biotechnologies, Madison, WI) was added, and
the samples were vortexed briefly, then centrifuged at
22,000 × g for 10 min. The supernatant was removed and
the protein pellet was discarded. The supernatant was
mixed with 500 μL isopropanol and inverted to mix. The
mixture was added to a spin column from the Genomic
DNA Isolation Kit (Life Technologies, Grand Island, NY),
and the remaining steps were followed according to
manufacturer’s protocol. The samples were eluted with
50 μL Elution Buffer (Life Technologies, Grand Island,
NY). For each set of extractions, one blank swab ex-
posed to laboratory air was processed as a negative
control.
The V4 region of the 16S rRNA gene was amplified using
barcoded primers for the Illumina platform as previously
described [36]. Sequencing was performed on the MiSeq
instrument (Illumina, San Diego, CA) using 150 base
paired-end chemistry at the University of Pennsylvania
Next Generation Sequencing Core. As a positive control
and for run-to-run quality control, we amplified and se-
quenced Genomic DNA from Microbial Mock CommunityB (Even, Low Concentration), v5.1 L, for 16S RNA Gene
Sequencing, HM-782D, obtained through BEI Resources,
NIAID, and NIH as part of the Human Microbiome
Project.
The 16S rDNA sequencing data and metadata generated
in this study have been submitted to the NCBI Sequence
Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra/)
under Bioproject SRP042152 and accession numbers
SRX548769-SRX548772.
16S rRNA gene analysis
Paired-end reads were assembled using PANDAseq [37],
and quality filtered to include sequences with a Q
score ≥30. mothur v.1.25.0 [38] was employed to remove
sequences <248 bp and >255 bp in length and sequences
with homopolymers >10 bp in length. QIIME v. 1.6 [39]
was used for further downstream processing and ana-
lyses. OTUs were defined using 97% sequence similarity
with CD-HIT [40,41], and a representative sequence from
each OTU containing ≥10 sequences was chosen for down-
stream analyses (based on the most abundant sequence).
Chimeric sequences were removed using ChimeraSlayer
[42]. Representative sequences were assigned to genera
using the Ribosomal Database Project (RDP) classifier v 2.2
[43], multiple sequence alignment was performed using
PyNAST [44], and a phylogeny was built with FastTree
[45]. The samples were rarified to 10,000 sequences per
sample for calculating alpha- and beta-diversity metrics.
Bioinformatics quality assurance
For quality control purposes, water and processed blank
samples were sequenced and analyzed through the bio-
informatics pipeline. Taxa that were present in the water or
laboratory air blank samples at >4 standard deviations
above the mean when compared to the other sample types
were removed, in addition to sequences identified as cyano-
bacteria or ‘unclassified’ (Additional file 11: Table S6). For
further quality control assurance and to ensure run-to-run
reproducibility, genomic DNA from Microbial Mock Com-
munity B (BEI Resources) was sequenced and the expected
sequences were compared to the obtained sequences. Pub-
lished best practices were used as guidelines [46].
Statistics
Alpha diversity and taxonomical relative abundances are
reported as the median with standard deviation. P values
were calculated using the Wilcoxon rank-sum test and
adjusted for multiple comparisons using the false discovery
rate (FDR) correction. Statistical tests were run in R v. 3.0.3
[47]. To determine which factors were most important in
determining microbial composition, statistical tests were
performed using the non-parametric analysis of similarities
(ANOSIM) with four different distance metrics [48]:
weighted UniFrac, unweighted UniFrac, Bray-Curtis, and
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formed using unadjusted and adjusted logistic regression
analysis, accounting for correlation within subject and
household, in Stata 13 (StataCorp, College Station, TX).
Network analyses comparing OTU interactions in MRSA
carriers to non-carriers were conducted using the CoNet
plugin [49] in Cytoscape [50]. Spearman rank correlation
coefficients were used to calculate positive and negative
interactions, and significance of interactions was tested
using the Fisher’s Z transformation and a p value threshold
of 0.05, corrected for multiple testing using the Benjamini-
Hochberg method. Only significant interactions were in-
cluded in the network.
Availability of supporting data
The data sets supporting the results of this article are
included with the article and its additional files.
Additional files
Additional file 1: Table S1. Sequence counts per host species and site
ID. The mean, media, and range of sequences obtained by Illumina 16S
rRNA sequencing are listed.
Additional file 2: Figure S1. The genus-level “pocket pet” nasal
planum (NP) and oral cavity (OC) microbiota. Microbiota of the four
“pocket pet” species are shown with the top 25 pocket pet microbiome
genera. A) Hamster oral cavities and nasal plana, B) ferret oral cavity and
nasal planum, C) rabbit oral cavity and nasal planum, and D) sugar glider
oral cavity/nasal planum combined sample.
Additional file 3: Table S2. Genus-level relative abundance. A
complete genus-level relative abundance table of all samples.
Additional file 4: Table S3. Core microbiomes. Core OTUs present in
each sampled host species and anatomical site. OTUs present in 90% of
samples are in non-bold text; OTUs present in 100% of samples are in
bold and italic text.
Additional file 5: Figure S2. OTU network inference of nasal microbiomes
according to MRSA carrier status. Network connectivities of OTUs present at
greater than 0.1% relative abundance in MRSA carriers (n = 4) (A) and in
MRSA non-carriers (n = 22) (B). The red lines represent a negative correlation
(mutual exclusion) and the green lines represent a positive correlation
(co-present) as calculated by Spearman rank correlation coefficients.
Additional file 6: Figure S3. Relative abundance charts depicting
site-specific feline microbiota over two visits, 3 months apart. A) Cat oral cavity;
B) cat nares. The numbers on the x-axis correspond to the study subject
number. The top ten median taxa for each sample site are used in the legend.
Additional file 7: Figure S4. Relative abundance charts depicting canine
site-specific microbiota over two visits, 3 months apart. A) Dog oral cavity;
B) dog nares. The numbers on the x-axis correspond to the study subject
number. The top ten median taxa for each sample site are used in the legend.
Additional file 8: Figure S5. Relative abundance charts depicting
human site-specific microbiota over two visits, 3 months apart. A) Human
inguinal crease/axillae, B) human nares, and C) healing human lesions.
The numbers on the x-axis correspond to the study subject number. The
top ten median taxa for each sample site are used in the legend.
Additional file 9: Table S4. Core microbiomes over two visits, 3
months apart. Taxa present in 90% samples at both visits 1 and 2. Taxa
present in 100% of samples at visit 1 and visit 2 are denoted with bold
italics. Median relative abundance levels are reported, and a Wilcoxon
rank-sum tests were conducted to assess if taxa levels were significantly
different between the two time visits. The total core compositions at
baseline and the 3-month visit are additionally reported.Additional file 10: Table S5. Species identification using the BD Phoenix
system of cultured non-aureus isolates in the genus Staphylococcus from
human nares and lesions according to visit. The section sign (§) indicates
participants living in households without pets. Dagger (†) indicates
participants at the 3-month visit who reported compliance with
decolonization treatment between baseline and 3-month visits.
Additional file 11: Table S6. Putative contaminants removed from 16S
rRNA sequence analysis. The taxa that were removed due to their higher
abundance (4 standard deviations above the mean) in water and blank
processed swabs compared to pet and human samples.
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